Virtual Medicinal Product (VMP)
-
Alfuzosin 10mg modified-release tablets
Name Details
Current Name
Alfuzosin 10mg modified-release tablets
|
Start Date
16-12-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release tablet
- Ontology Form/Route
- tabletmodified-release.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G04CA01
BNF |
Current BNF
07040100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
07040100
|
Start Date
10-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
38897311000001105 |
19-08-2020 |
|
326522002 |
24-10-2018 |
18-08-2020 |
35896811000001105 |
17-10-2018 |
23-10-2018 |
326522002 |
16-12-2002 |
16-10-2018 |
VMP Ingredients
Name
Alfuzosin hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10
Strength and UOM (Dmr)
Parent Products
-
VTM
Alfuzosin
-
VMP
(Current) Alfuzosin 10mg modified-release tablets
Virtual Medicinal Product Pack (VMPP) Information